Specialized Accessory Devices to Drive US Market Growth

According to a new report by Millennium Research Group (MRG), the US market for accessory devices, comprising percutaneous transluminal coronary angioplasty (PTCA) guidewires, diagnostic catheters, PTCA guiding catheters, intravascular ultrasound (IVUS) catheters, and introducer sheaths, was worth nearly $400 million in 2004 and will exceed $500 million by 2009.

(PRWEB) August 3, 2005 -- The aging US population, which is at heightened risk for coronary artery disease (CAD), is fueling a growing demand for less invasive percutaneous coronary intervention (PCI) procedures to treat the disease. PCI procedure volumes are rising annually, contributing to the increased use of specific accessory devices required for every PCI procedure. According to a new report by Millennium Research Group (MRG), the US market for accessory devices, comprising percutaneous transluminal coronary angioplasty (PTCA) guidewires, diagnostic catheters, PTCA guiding catheters, intravascular ultrasound (IVUS) catheters, and introducer sheaths, was worth nearly $400 million in 2004 and will exceed $500 million by 2009.

An increasing patient population, coupled with escalating demand among physicians for less invasive and more effective accessory devices, has prompted manufacturers to develop products for specialized procedures and clinical situations. Specialty accessories, such as guidewires designed for treatment of chronic total occlusions, and accessories that incorporate new functionalities such as IVUS catheters, enable physicians to diagnose and treat CAD more effectively, while commanding a premium price. The development of specialized products will also further expand the potential CAD patient pool by enabling physicians to treat individuals with advanced cases of coronary blockage previously ineligible for a PCI procedure.

US Markets for Accessory Devices 2005 is part of MRGs 2005 Marketfocus series, which offers US and European brand- and quarter-level coverage of coronary stents, PTCA balloons, and accessory devices as well as US coverage of plaque modification. MRG has also relaunched its Global Interventional Cardiology series, which features in-depth analysis of IC-related markets in the US, with forthcoming coverage of Europe, Japan, Latin America, and Asia Pacific. Global competitive coverage includes Abbott Vascular (ABT), Boston Scientific (BSX), Cordis (JNJ), Guidant (GDT), and Medtronic (MDT), among others.

A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.

Contact:

Derrick Navarro

416-364-7776

dnavarro@mrg.net

###